Giuseppe Remuzzi

Research interests

Publications

• Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

  The Lancet · 2021 · https://doi.org/10.1016/s0140-6736(21)00590-0

• COVID-19 and Italy: what next?

  The Lancet · 2020 · https://doi.org/10.1016/s0140-6736(20)30627-9

• Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy

  JAMA · 2017 · https://doi.org/10.1001/jama.2017.9362

• Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

  The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)30788-2

• Chronic kidney disease

  Nature Reviews Disease Primers · 2017 · https://doi.org/10.1038/nrdp.2017.88

• Panethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-Analysis

  PLoS ONE · 2016 · 10.1371/journal.pone.0147601

• Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy

  JAMA · 2015 · 10.1001/jama.2015.10081

• International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology

  The Lancet · 2015 · 10.1016/s0140-6736(15)60126-x

• Organoid Models and Applications in Biomedical Research

  ˜The œNephron journals/Nephron journals · 2015 · https://doi.org/10.1159/000433566

• Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

  New England Journal of Medicine · 2013 · 10.1056/nejmoa1208981

• Overview of Complement Activation and Regulation

  Seminars in Nephrology · 2013 · 10.1016/j.semnephrol.2013.08.001

• Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

  New England Journal of Medicine · 2013 · 10.1056/nejmoa1306033

• The contribution of chronic kidney disease to the global burden of major noncommunicable diseases

  Kidney International · 2011 · 10.1038/ki.2011.368

• Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype

  Clinical Journal of the American Society of Nephrology · 2010 · 10.2215/cjn.02210310

• Angiotensin II revisited: new roles in inflammation, immunology and aging

  EMBO Molecular Medicine · 2010 · 10.1002/emmm.201000080

• A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

  New England Journal of Medicine · 2009 · https://doi.org/10.1056/nejmoa0907845

• Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis

  New England Journal of Medicine · 2009 · https://doi.org/10.1056/nejmoa0810177

• Atypical Hemolytic–Uremic Syndrome

  New England Journal of Medicine · 2009 · 10.1056/nejmra0902814

• How Does Proteinuria Cause Progressive Renal Damage?

  Journal of the American Society of Nephrology · 2006 · 10.1681/asn.2006040377

• Mesenchymal Stem Cells Are Renotropic, Helping to Repair the Kidney and Improve Function in Acute Renal Failure

  Journal of the American Society of Nephrology · 2004 · 10.1097/01.asn.0000128974.07460.34

• Delayed graft function in kidney transplantation

  The Lancet · 2004 · 10.1016/s0140-6736(04)17406-0

• Preventing Microalbuminuria in Type 2 Diabetes

  New England Journal of Medicine · 2004 · 10.1056/nejmoa042167

• Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL

  Kidney International · 2004 · 10.1111/j.1523-1755.2004.00653.x

• Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

  New England Journal of Medicine · 2001 · https://doi.org/10.1056/nejmoa011161

• Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

  The Lancet · 1999 · 10.1016/s0140-6736(98)10363-x

• Pathophysiology of Progressive Nephropathies

  New England Journal of Medicine · 1998 · 10.1056/nejm199811123392007

• von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome

  New England Journal of Medicine · 1998 · 10.1056/nejm199811263392202

Current projects

No projects listed.